Filing a Gadolinium Lawsuit for Nephrogenic Systemic Fibrosis

Information About Filing a Gadolinium Lawsuit for Nephrgenic Systemic Fibrosis (NSF) Patients

Nearly all cases of Nephrogenic Systemic Fibrosis can be directly attributed to gadolinium injections in patients with advanced or end-stage kidney disease. This link was first announced by the FDA in 2006, at which time they suggested additional warnings be included in with gadolinium distribution.

Gadolinium helps doctors read MRIs, but it has also recently been linked to serious injuries. If you are considering filing a gadolinium lawsuit, our NSF attorneys understand the complex issues surrounding people that have been affected by Nephgrogenic Systemic Fibrosis and gadolinium contrast dye injections.

How Our Nephrogenic Systemic Fibrosis (NSF) Attorneys Can Help You

If you have developed NSF as the result of gadolinium in your system, managing your complex medical recovery and expenses will be a challenge. You also face a potentially complicated legal situation if you choose to file a gadolinium lawsuit.
But the Simmons firm can help.

The Simmons firm has experience in litigating complex medical matters, including filing gadolinium and NSF lawsuits. We have taken a leadership role in standing up for individuals who have been injured by dangerous or defective drugs and devices and over the last few years have represented thousands of pharmaceutical clients and recovered verdicts and settlements totaling more than $200 million.*

^{* Please note that recovery results vary per client. The recovery amounts in each case reflect the specific facts of that case. Further, recovery amounts in past cases are not a guarantee of future results.}